Vanguard Group
COGT icon

Vanguard Group’s Cogent Biosciences COGT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$46.8M Buy
6,522,951
+464,613
+8% +$3.34M ﹤0.01% 2155
2025
Q1
$36.3M Sell
6,058,338
-75,042
-1% -$450K ﹤0.01% 2238
2024
Q4
$47.8M Buy
6,133,380
+418,975
+7% +$3.27M ﹤0.01% 2175
2024
Q3
$61.7M Buy
5,714,405
+454,526
+9% +$4.91M ﹤0.01% 2083
2024
Q2
$44.3M Sell
5,259,879
-505,826
-9% -$4.26M ﹤0.01% 2194
2024
Q1
$38.7M Buy
5,765,705
+1,231,050
+27% +$8.27M ﹤0.01% 2274
2023
Q4
$26.7M Buy
4,534,655
+161,344
+4% +$949K ﹤0.01% 2466
2023
Q3
$42.6M Sell
4,373,311
-63,310
-1% -$617K ﹤0.01% 2203
2023
Q2
$52.5M Buy
4,436,621
+900,362
+25% +$10.7M ﹤0.01% 2159
2023
Q1
$38.2M Buy
3,536,259
+70,467
+2% +$760K ﹤0.01% 2297
2022
Q4
$40.1M Buy
3,465,792
+282,022
+9% +$3.26M ﹤0.01% 2293
2022
Q3
$47.5M Buy
3,183,770
+597,966
+23% +$8.92M ﹤0.01% 2208
2022
Q2
$23.3M Buy
2,585,804
+942,835
+57% +$8.5M ﹤0.01% 2567
2022
Q1
$12.3M Sell
1,642,969
-9,764
-0.6% -$73.1K ﹤0.01% 3041
2021
Q4
$14.2M Buy
1,652,733
+55,617
+3% +$477K ﹤0.01% 3032
2021
Q3
$13.4M Sell
1,597,116
-9,673
-0.6% -$81.3K ﹤0.01% 3079
2021
Q2
$13M Sell
1,606,789
-527,454
-25% -$4.28M ﹤0.01% 3073
2021
Q1
$18.7M Buy
2,134,243
+1,275,692
+149% +$11.2M ﹤0.01% 2818
2020
Q4
$9.64M Buy
858,551
+295,456
+52% +$3.32M ﹤0.01% 3012
2020
Q3
$1.32M Buy
563,095
+60,515
+12% +$142K ﹤0.01% 3596
2020
Q2
$231K Sell
502,580
-21,750
-4% -$10K ﹤0.01% 3910
2020
Q1
$217K Sell
524,330
-662
-0.1% -$274 ﹤0.01% 3851
2019
Q4
$378K Sell
524,992
-1,124
-0.2% -$809 ﹤0.01% 3848
2019
Q3
$758K Buy
526,116
+118,304
+29% +$170K ﹤0.01% 3717
2019
Q2
$1.07M Sell
407,812
-34,008
-8% -$89.1K ﹤0.01% 3657
2019
Q1
$1.94M Buy
441,820
+257,394
+140% +$1.13M ﹤0.01% 3462
2018
Q4
$812K Sell
184,426
-367,954
-67% -$1.62M ﹤0.01% 3623
2018
Q3
$5.69M Buy
552,380
+22,510
+4% +$232K ﹤0.01% 3184
2018
Q2
$7.6M Buy
529,870
+155,770
+42% +$2.24M ﹤0.01% 3038
2018
Q1
$4.16M Buy
+374,100
New +$4.16M ﹤0.01% 3221